Not applicableLooking for participantsNCT06787105What this trial is testingFruquintinib in Patients With Metastatic Colorectal CancerWho this might be right forMetastatic Colorectal Cancer (mCRC) iOMEDICO AG 150
Post-approval studies (Phase 4)UnknownNCT02301962What this trial is testingPhase IV Panitumumab Study in Indian Subjects With Metastatic Colorectal CancerWho this might be right forCancer Dr. Reddy's Laboratories Limited 58
Testing effectiveness (Phase 2)Looking for participantsNCT03093116What this trial is testingRepotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 RearrangementsWho this might be right forLocally Advanced Solid TumorsMetastatic Solid Tumors Turning Point Therapeutics, Inc. 500
Early research (Phase 1)Temporarily pausedNCT05958199What this trial is testingNPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7Who this might be right forMetastatic Malignant Neoplasm NextPoint Therapeutics, Inc. 131
Early research (Phase 1)Study completedNCT02900664What this trial is testingPDR001 in Combination With CJM112, EGF816, Ilaris® (Canakinumab) or Mekinist® (Trametinib)Who this might be right forColorectal Cancer, Triple Negative Breast Cancer, NSCLC - Adenocarcinoma Novartis Pharmaceuticals 283
Early research (Phase 1)Looking for participantsNCT06242470What this trial is testingMGC026 in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorAdvanced CancerMetastatic Cancer+19 more MacroGenics 250
Testing effectiveness (Phase 2)WithdrawnNCT00346099What this trial is testingStudy of Panitumumab Given First With Capecitabine and Oxaliplatin (CAPOX) and Then With Capecitabine and Radiation of the Pelvis for Treatment of Patients With Rectal Cancers That May or May Not Have Spread Beyond the RectumWho this might be right forRectal CancerNeoplasm Metastasis NSABP Foundation Inc
Early research (Phase 1)Looking for participantsNCT07094204What this trial is testingFind a Suitable Dose of ASP5834 in Adults With Solid TumorsWho this might be right forSolid TumorNon-Small-Cell Lung CancerPancreatic Ductal Adenocarcinoma+1 more Astellas Pharma Inc 364
Testing effectiveness (Phase 2)UnknownNCT03608046What this trial is testingAvelumab Combined With Cetuximab and Irinotecan for Treatment Refractory Metastatic Colorectal Microsatellite Stable CancerWho this might be right forColorectal Neoplasms, Malignant Cliniques universitaires Saint-Luc- Université Catholique de Louvain 59
Testing effectiveness (Phase 2)Ended earlyNCT02842580What this trial is testingDe-escalation Chemotherapies Versus Escalation in Non Pre-treated Unresectable Patients With Metastatic Colorectal CancerWho this might be right forColorectal Neoplasms Federation Francophone de Cancerologie Digestive 21
Testing effectiveness (Phase 2)Study completedNCT03241173What this trial is testingA Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or Metastatic MalignanciesWho this might be right forAdvanced Malignancies Incyte Biosciences International Sàrl 52
Testing effectiveness (Phase 2)Active Not RecruitingNCT02568267What this trial is testingBasket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)Who this might be right forBreast CancerCholangiocarcinomaColorectal Cancer+13 more Hoffmann-La Roche 534
Early research (Phase 1)Ended earlyNCT04553692What this trial is testingPhase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed CancersWho this might be right forSolid TumorColorectal CancerNon Hodgkin Lymphoma+5 more IGM Biosciences, Inc. 272
Testing effectiveness (Phase 2)Study completedNCT02983045What this trial is testingA Dose Escalation and Cohort Expansion Study of NKTR-214 in Combination With Nivolumab and Other Anti-Cancer Therapies in Patients With Select Advanced Solid TumorsWho this might be right forMelanomaRenal Cell CarcinomaNon Small Cell Lung Cancer+4 more Nektar Therapeutics 557
Testing effectiveness (Phase 2)WithdrawnNCT04464967What this trial is testingSafety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR CancersWho this might be right forAdvanced Solid TumorMetastatic CancerHER2-positive Breast Cancer+14 more NKGen Biotech, Inc.
Testing effectiveness (Phase 2)Active Not RecruitingNCT05131919What this trial is testingPembrolizumab for Locally Advanced, Irresectable, Non-metastatic dMMR Colorectal CancersWho this might be right forColorectal Cancer The Netherlands Cancer Institute 25
Testing effectiveness (Phase 2)Study completedNCT01836653What this trial is testingAchievement of Improved Survival by Molecular Targeted Chemotherapy and Liver Resection for Not Optimally Resectable Colorectal Liver MetastasesWho this might be right forLiver Only Metastasis From KRAS Exon 2 Wild Type (Under Protocol 1.0-1.2 Edition) and RAS Wild Type (Under Protocol 2.0 Edition) Colorectal Cancer EPS Corporation 122
Not applicableStudy completedNCT00253383What this trial is testingEarly Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer PatientsWho this might be right forCancer Dartmouth-Hitchcock Medical Center 329
Not applicableStudy completedNCT05461430What this trial is testingMass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)Who this might be right forPleural Effusion, MalignantAscites, MalignantCarcinoma+29 more Travera Inc 72
Testing effectiveness (Phase 2)Looking for participantsNCT06526819What this trial is testingSMP-3124LP in Adults With Advanced Solid TumorsWho this might be right forSolid Tumor Sumitomo Pharma America, Inc. 120